MicroVue SC5b-9 Plus EIA (CE-IVD), Model A029. An enzyme immunoassay for the quantitation of SC5...

FDA Device Recall #Z-1499-2018 — Class III — November 3, 2015

Recall Summary

Recall Number Z-1499-2018
Classification Class III — Low risk
Date Initiated November 3, 2015
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Diagnostic Hybrids, Inc.
Location Athens, OH
Product Type Devices
Quantity 72 kits

Product Description

MicroVue SC5b-9 Plus EIA (CE-IVD), Model A029. An enzyme immunoassay for the quantitation of SC5b-9 complex present in human plasma or serum.

Reason for Recall

A component of the kit was found to contain bacterial contamination.

Distribution Pattern

Worldwide Distribution - USA (nationwide) to the states of : CO, CT, IA, IL, MN, MO, NC, NY, OH TX, and UT., and to the countries of : Switzerland, India, Hong Kong, and Japan.

Lot / Code Information

Lot 052419

Other Recalls from Diagnostic Hybrids, Inc.

Recall # Classification Product Date
Z-1496-2018 Class II MicroVue CIC-C1q EIA, Model A001. An enzyme im... Apr 4, 2017
Z-1520-2018 Class III Quidel MicroVue Intact PTH EIA, Model 8044. An... Oct 26, 2016
Z-1797-2018 Class II MicroVue BAP EIA, Model 8012, provides a quanti... Jul 14, 2016
Z-1498-2018 Class III MicroVue SC5b-9 Plus EIA (RUO), Model A020. Res... Nov 3, 2015
Z-1497-2018 Class III MicroVue CIC-C1q EIA, Model A001. The MicroVue ... Nov 3, 2015

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.